SEOM Clinical Guideline in ovarian cancer (2016)

about

SEOM guidelines 2016: an update.

P2860

Q54287716-12F3A2FF-6F06-4F96-8446-702B8C93FA15

P2860

SEOM Clinical Guideline in ovarian cancer (2016)

Item

http://www.wikidata.org/entity/Q37475168

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

SEOM Clinical Guideline in ovarian cancer (2016)

@en

SEOM Clinical Guideline in ovarian cancer

@nl

type

Item

label

SEOM Clinical Guideline in ovarian cancer (2016)

@en

SEOM Clinical Guideline in ovarian cancer

@nl

prefLabel

SEOM Clinical Guideline in ovarian cancer (2016)

@en

SEOM Clinical Guideline in ovarian cancer

@nl

P1476

SEOM Clinical Guideline in ovarian cancer (2016)

@en

P2093

A Casado

http://www.w3.org/2001/XMLSchema#string

A González-Martín

http://www.w3.org/2001/XMLSchema#string

A Redondo

http://www.w3.org/2001/XMLSchema#string

A Santaballa

http://www.w3.org/2001/XMLSchema#string

E Guerra

http://www.w3.org/2001/XMLSchema#string

I Romero

http://www.w3.org/2001/XMLSchema#string

J Martinez

http://www.w3.org/2001/XMLSchema#string

N Laínez

http://www.w3.org/2001/XMLSchema#string

P Barretina

http://www.w3.org/2001/XMLSchema#string

Y García

http://www.w3.org/2001/XMLSchema#string

P2860

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

The effect of lymphadenectomy on survival and recurrence in patients with ovarian cancer: a systematic review and meta-analysis.

Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

SEOM guideline in ovarian cancer 2014.

P2888

s12094-016-1588-8

P304

1206-1212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-016-1588-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27905052

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5138249

http://www.w3.org/2001/XMLSchema#string

SEOM Clinical Guideline in ovarian cancer (2016)

about

P2860

P2860

SEOM Clinical Guideline in ovarian cancer (2016)

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932